MX345469B - Combinacion de (3s,3s') 4,4'-disulfandiilbis(acido 3-aminobutan 1-sulfonico) y un segundo agente antihipertensivo. - Google Patents
Combinacion de (3s,3s') 4,4'-disulfandiilbis(acido 3-aminobutan 1-sulfonico) y un segundo agente antihipertensivo.Info
- Publication number
- MX345469B MX345469B MX2014007547A MX2014007547A MX345469B MX 345469 B MX345469 B MX 345469B MX 2014007547 A MX2014007547 A MX 2014007547A MX 2014007547 A MX2014007547 A MX 2014007547A MX 345469 B MX345469 B MX 345469B
- Authority
- MX
- Mexico
- Prior art keywords
- disulfanediylbis
- aminobutane
- combination
- sulfonic acid
- antihypertensive agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se relaciona a una composición farmacéutica que comprende, en al menos un soporte o vehículo farmacéuticamente aceptable, una combinación de (3S,3S') 4,4'-disulfandiilbis(ácido 3-aminobutan 1-sulfónico) o una sal farmacéuticamente aceptable o solvato de la misma y un segundo ingrediente activo seleccionado del grupo que consiste de inhibidores de enzima que convierten a angiotensina I y antagonistas tipo 1 del receptor de angiotensina II. Dicha composición es particularmente útil para el tratamiento de hipertensión y enfermedades y afecciones relacionadas.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11306735 | 2011-12-21 | ||
| PCT/EP2012/076607 WO2013092984A1 (en) | 2011-12-21 | 2012-12-21 | Combination of (3s,3s') 4,4'-disulfanediylbis(3-aminobutane 1-sulfonic acid) and a second antihypertensive agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2014007547A MX2014007547A (es) | 2014-08-01 |
| MX345469B true MX345469B (es) | 2017-02-01 |
Family
ID=47522577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014007547A MX345469B (es) | 2011-12-21 | 2012-12-21 | Combinacion de (3s,3s') 4,4'-disulfandiilbis(acido 3-aminobutan 1-sulfonico) y un segundo agente antihipertensivo. |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US10959938B2 (es) |
| EP (1) | EP2793878B1 (es) |
| JP (2) | JP6212500B2 (es) |
| KR (1) | KR20140116879A (es) |
| CN (2) | CN104220062B (es) |
| AU (1) | AU2012356895B2 (es) |
| BR (1) | BR112014015276B1 (es) |
| CA (1) | CA2859704C (es) |
| CY (1) | CY1118711T1 (es) |
| DK (1) | DK2793878T3 (es) |
| EA (1) | EA028718B1 (es) |
| ES (1) | ES2619027T3 (es) |
| HK (1) | HK1203051A1 (es) |
| HR (1) | HRP20170267T1 (es) |
| HU (1) | HUE033403T2 (es) |
| IL (1) | IL233156B (es) |
| IN (1) | IN2014DN05787A (es) |
| LT (1) | LT2793878T (es) |
| MX (1) | MX345469B (es) |
| PL (1) | PL2793878T3 (es) |
| PT (1) | PT2793878T (es) |
| RS (1) | RS55774B1 (es) |
| SI (1) | SI2793878T1 (es) |
| WO (1) | WO2013092984A1 (es) |
| ZA (1) | ZA201405266B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN2014DN05787A (es) * | 2011-12-21 | 2015-05-15 | Quantum Genomics | |
| TW202207917A (zh) * | 2020-05-06 | 2022-03-01 | 法商量子基因科技有限公司 | 包含腦胺肽酶抑制劑、利尿劑及全身性腎素－血管收縮素系統阻斷劑之醫藥組合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2773712B1 (fr) * | 1998-01-16 | 2000-06-02 | Inst Nat Sante Rech Med | Composition pharmaceutique comprenant au moins un inhibiteur de l'aminopeptidase a |
| DK1525188T3 (da) * | 2002-07-16 | 2008-11-17 | Inst Nat Sante Rech Med | Hidtil ukendte derivater af 4,4-dithiobis-(3-aminobutan-1-sulfonater) og sammensætninger, der indeholder dem |
| FR2858617A1 (fr) * | 2003-08-06 | 2005-02-11 | Inst Nat Sante Rech Med | Derives de 4',4'-dithiobis-(3-aminobutane-1-sulfonate-1- sulfonates) nouveaux et compositions les contenant |
| US20080014187A1 (en) * | 2006-07-15 | 2008-01-17 | Bryant Villeponteau | Compositions and Methods for Treating Hypertension and Inflammation |
| IN2014DN05787A (es) * | 2011-12-21 | 2015-05-15 | Quantum Genomics |
-
2012
- 2012-12-21 IN IN5787DEN2014 patent/IN2014DN05787A/en unknown
- 2012-12-21 PT PT128129871T patent/PT2793878T/pt unknown
- 2012-12-21 CN CN201280069935.4A patent/CN104220062B/zh not_active Expired - Fee Related
- 2012-12-21 EP EP12812987.1A patent/EP2793878B1/en active Active
- 2012-12-21 PL PL12812987T patent/PL2793878T3/pl unknown
- 2012-12-21 HU HUE12812987A patent/HUE033403T2/en unknown
- 2012-12-21 CN CN201810509836.2A patent/CN109464432A/zh active Pending
- 2012-12-21 KR KR1020147020364A patent/KR20140116879A/ko active Search and Examination
- 2012-12-21 RS RS20170225A patent/RS55774B1/sr unknown
- 2012-12-21 DK DK12812987.1T patent/DK2793878T3/en active
- 2012-12-21 US US14/367,408 patent/US10959938B2/en active Active
- 2012-12-21 JP JP2014548062A patent/JP6212500B2/ja active Active
- 2012-12-21 LT LTEP12812987.1T patent/LT2793878T/lt unknown
- 2012-12-21 BR BR112014015276-4A patent/BR112014015276B1/pt active IP Right Grant
- 2012-12-21 EA EA201400724A patent/EA028718B1/ru unknown
- 2012-12-21 MX MX2014007547A patent/MX345469B/es active IP Right Grant
- 2012-12-21 WO PCT/EP2012/076607 patent/WO2013092984A1/en active Application Filing
- 2012-12-21 SI SI201230901A patent/SI2793878T1/sl unknown
- 2012-12-21 AU AU2012356895A patent/AU2012356895B2/en active Active
- 2012-12-21 ES ES12812987.1T patent/ES2619027T3/es active Active
- 2012-12-21 CA CA2859704A patent/CA2859704C/en active Active
-
2014
- 2014-06-16 IL IL233156A patent/IL233156B/en active IP Right Grant
- 2014-07-18 ZA ZA2014/05266A patent/ZA201405266B/en unknown
-
2015
- 2015-04-13 HK HK15103574.1A patent/HK1203051A1/xx not_active IP Right Cessation
-
2017
- 2017-02-20 HR HRP20170267TT patent/HRP20170267T1/hr unknown
- 2017-03-09 CY CY20171100303T patent/CY1118711T1/el unknown
- 2017-07-21 JP JP2017141918A patent/JP6726138B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201101672A1 (ru) | Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина | |
| EA201100691A1 (ru) | Антагонисты рецепторов лизофосфатидной кислоты | |
| NO20073959L (no) | Kinazolinderivat, fremgangsmate for fremstilling og anvendelse derav for inhibering av vekst av kreftceller | |
| MX2009011487A (es) | Agentes antihipertensivos de doble accion. | |
| MX2011011428A (es) | Derivados de acido sulfamoilbenzoico como antagonistas de trpm8. | |
| WO2010011821A3 (en) | Dual-acting antihypertensive agents | |
| WO2008057802A3 (en) | Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same | |
| WO2011041694A3 (en) | Compounds as lysophosphatidic acid receptor antagonists | |
| WO2011017350A3 (en) | Compounds as lysophosphatidic acid receptor antagonists | |
| FR2906140B1 (fr) | Forme galenique pour l'administration par voie trans-muqueuse de principes actifs | |
| EP2178869A4 (en) | INDOLE COMPOUNDS AS INHIBITORS OF CELL NECROSIS | |
| EA201290191A1 (ru) | N1-ПИРАЗОЛОСПИРОКЕТОНОВЫЕ ИНГИБИТОРЫ АЦЕТИЛ-KoA-КАРБОКСИЛАЗЫ | |
| MA32442B1 (fr) | Inhibiteurs de la syk protéine kinase | |
| EP3626253A3 (en) | Stable formulations of linaclotide | |
| JO2973B1 (en) | Fumarate salt for (alpha-beta-R) -6-bromo-alpha-[2- (methylamino) ethyl-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinoline ethanol | |
| EP3915566A4 (en) | COMPOSITION FOR THE PREVENTION OR TREATMENT OF INFLAMMATORY BOWEL DISEASE, CONTAINING TAURODEOXYCHOLIC ACID OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS THE ACTIVE INGREDIENT | |
| MA33132B1 (fr) | Derives pyrazole utilises comme antagonistes du recepteur ccr4 | |
| UA93709C2 (ru) | 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций | |
| WO2007081808A3 (en) | Compounds and derivatives for the treatment of medical conditions by modulating hormone-sensitive lipase activity | |
| MY144613A (en) | Formulations of suberoylanilide hydroxamic acid and methods for producing same | |
| MX2014007547A (es) | Combinacion de (3s,3s') 4,4'-disulfandiilbis(acido 3-aminobutan 1-sulfonico) y un segundo agente antihipertensivo. | |
| MX2010003594A (es) | Formas cristalinas de sal sodica de dmxaa. | |
| SG10201809506TA (en) | Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions | |
| WO2007110765A3 (en) | Processes for the preparation of octreotide | |
| MX2009005329A (es) | Composiciones farmaceuticas anticonvulsivas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |